User menu

Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment.

Bibliographic reference Taper, Henryk ; de Gerlache, J ; Lans, M. ; Roberfroid, Marcel. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment.. In: International journal of cancer. Journal international du cancer, Vol. 40, no. 4, p. 575-9 (1987)
Permanent URL http://hdl.handle.net/2078.1/11810
  1. Ardenne, Arch. Geschwulstforsch., 31, 252 (1969)
  2. Ejartholeyns, Cancer Res., 41, 5158 (1981)
  3. Begleltbr, Cancer Res., 43, 481 (1983)
  4. Benade, Oncology, 23, 33 (1969)
  5. Bodansky, Cancer Res., 11, 238 (1951)
  6. Biam, Nature (lond.), 284, 629 (1980)
  7. Cameron, Cancer Res., 39, 663 (1979)
  8. Cappucino, Cancer Res., 26, 689 (1966)
  9. Chapman, N. Engl. J. Med., 26, 1429 (1979)
  10. Chiou, J. Biochem., 94, 1259 (1983)
  11. Connor William G., Gerner Eugene W., Miller Robert C., Boone Max L. M., Prospects for Hyperthermia in Human Cancer Therapy : Part II: Implications of Biological and Physical Data for Applications of Hyperthermia to Man, 10.1148/123.2.497
  12. Daoust, Cancer Res., 23, 131 (1963)
  13. DAOUST R., CANTERO A., THE DISTRIBUTION OF DEOXYRIBONUCLEASE IN NORMAL, CIRRHOTIC AND NEOPLASTIC RAT LIVERS, 10.1177/7.2.139
  14. Decosse, Surgery, 78, 608 (1975)
  15. Dische, Cancer clin. Trials, 3, 175 (1980)
  16. Edgar, Experientia, 25, 1214 (1969)
  17. Edgar, Nature (lond.), 227, 24 (1979)
  18. Fort, Histochemistry, 20, 150 (1969)
  19. Fujita, Cancer Res., 42, 309 (1982)
  20. Gautherie, J. Radial. Electrol. Med. nucl., 60, 685 (1979)
  21. Geran, Cancer Chemother. Rep., 3, 1 (1972)
  22. Gol-Winkel, Toxicology, 17, 237 (1980)
  23. Herman, Cancer Res., 41, 3840 (1981)
  24. Hung, Cancer Res., 41, 2783 (1981)
  25. Koch, J. cell. Physiol., 94, 299 (1978)
  26. Leith, Cancer Res., 42, 30 (1982)
  27. Leuchtenberger, Brit. J. exp. Path., 58, 625 (1977)
  28. Liehr, Cancer Res., 43, 4638 (1983)
  29. Lloyd, J. clin. Path., 25, 478 (1972)
  30. and (eds.), Modulation and mediation of cancer by vitamins. M. Langer, Basel (1983).
  31. Park, Cancer Res., 40, 1062 (1980)
  32. Pipkin G. E., Schlegel J. U., Nishimura R., Shultz G. N., Inhibitory Effect of L-Ascorbate on Tumor Formation in Urinary Bladders Implanted with 3-Hydroxyanthranilic Acid, 10.3181/00379727-131-33916
  33. Prasad, Life Sci., 29, 1387 (1981)
  34. Prasad, Proc. nat. Acad. Sci. (wash.), 76, 829 (1979)
  35. Reynolds, Cancer Res., 42, 1331 (1982)
  36. Rogan, Science, 224, 994 (1984)
  37. Samuni, Europ. J. Biochem., 137, 119 (1983)
  38. Schlegel, J. Urol., 103, 153 (1979)
  39. Taper H S, Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells., 10.1177/29.9.7288160
  40. Taper, Cancer, 28, 483 (1971)
  41. Taper, J. Neural. Sci., 12, 369 (1971a)
  42. Taper, Cancer, 47, 523 (1981)
  43. Taper, Cancer Res., 31, 913 (1971b)
  44. Taper, Cancer Res., 26, 143 (1966)
  45. Varga, Life Sci., 32, 1559 (1983)
  46. Waldo, Cancer, 8, 187 (1955)
  47. Waxman, Europ. J. Cancer clin. Oncoi, 18, 685 (1982)
  48. Yamafuji, Z. Krebsforsch., 76, 1 (1971)